. 2021 Jan 20;18(3):857. doi: 10.3390/ijerph18030857

Table 4.

Comorbidity and the values of obesity-related indices according to the severity of NAFLD in study participants.

	Absent (n = 1143)	Mild (n = 437)	Moderate (n = 347)	Severe (n = 42)	p
Diabetes mellitus history (%)	7.0	13.0 *	18.4 *	11.9	<0.001
Hypertension history (%)	20.5	29.7 *	33.7 *	23.8	<0.001
Hyperlipidemia history (%)	1.3	3.2	4.0 *	4.8	0.006
Obesity-related indices
BMI (kg/m²)	23.58 ± 3.44	25.66 ± 3.03 *	27.68 ± 3.77 *^,†	31.06 ± 4.23 *^,†,#	<0.001
WHtR	0.50 ± 0.06	0.53 ± 0.05 *	0.56 ± 0.06 *^,†	0.61 ± 0.05 *^,†,#	<0.001
WHR	0.85 ± 0.09	0.88 ± 0.07 *	0.90 ± 0.07 *^,†	0.93 ± 0.07 *^,†	<0.001
LAP	24.62 ± 22.78	42.36 ± 35.44 *	58.58 ± 50.38 *^,†	75.52 ± 43.83 *^,†,#	<0.001
BRI	3.44 ± 1.21	4.05 ± 1.03 *	4.66 ± 1.25 *^,†	5.60 ± 1.18 *^,†,#	<0.001
CI	1.20 ± 0.09	1.22 ± 0.08 *	1.24 ± 0.08 *^,†	1.28 ± 0.08 *^,†	<0.001
VAI	3.26 ± 2.51	5.21 ± 4.79 *	6.96 ± 9.27 *^,†	6.67 ± 3.95 *	<0.001
BAI	28.95 ± 4.49	30.26 ± 4.57 *	31.63 ± 5.76 *^,†	33.73 ± 4.03 *^,†	<0.001
AVI	13.36 ± 3.15	14.88 ± 3.02 *	16.54± 3.37 *^,†	19.37 ± 3.74 *^,†,#	<0.001
TyG index	8.35 ± 0.55	8.74 ± 0.61 *	9.03 ± 0.62 *^,†	9.08 ± 0.54 *^,†	<0.001
HSI	31.3 ± 4.6	34.9 ± 4.2 *	38.4 ± 5.1 *^,†	42.9 ± 5.5 *^,†,#	<0.001

Abbreviations are the same as in Table 1. * p < 0.05 compared with non-NAFLD; † p < 0.05 compared with mild NAFLD; # p < 0.05 compared with moderate NAFLD.